this summer attacking the development of genetically modified crops. "I happen to believe that this kind of genetic modification takes mankind into realms that belong to God and to God alone," he said. Numerous crop trials have been destroyed by protesters, and one U.K. group trashed a display of genetically modified wheat by the Biotechnology and Biological Sciences Research Council (BBSRC) at a spring farming show this year.
Supermarkets have responded quickly to such public concerns about genetically modified food. In the United Kingdom most of the major retailers have introduced plans to label products containing genetically modified ingredients even before a proposed EU regulation forces them to do so. And some are committed to reducing or eliminating such products (see sidebar).
U.S. and multinational biotechnology companies are increasingly alarmed and surprised at the level of resistance in Europe to what they see as safe and innocuous technology. They view the new techniques, which have been embraced by many farmers in the United States and elsewhere with little public concern, as a seamless extension of traditional plant breeding. The United States has already approved more than 30 genetically modified crops for commercial use, with many more under trial. From a standing start in 1996, 27% of U.S. plantings of soybean are now genetically modified to carry resistance to herbicides and the share is expected to grow rapidly. Some European consumers "are not accepting this product and the benefits of biotechnology as quickly, and that is creating trade problems," Hendrick Verfaille, president of the multinational biotech company Monsanto, told a recent conference of U.S. and Canadian seed traders in Toronto.
The EU has tried to bring order to the situation, but its directives, which guide national regulations, have come under fire from biotech companies as too opaque and ineffective and from critics for not taking wider public concerns into account. "Our biotechnology industry has expressed considerable frustration at the cumbersome and unpredictable procedures in the [EU] and at the length of time it takes for the EU to review and approve products for commercialization," says Tim Galvin of the U.S. Department of Agriculture's (USDA's) foreign service in Washington, D.C., who gave evidence to a British House of Lords inquiry on the introduction of genetically modified crops last month. "Unless Europe can sort out its review processes, we could see a trade war developing."
Grassroots movement
The reasons for Europe's apparent Luddism are many and complex. In some countries, there is a general abhorrence of any genetic manipulation because of Nazi abuses of genetics in the name of science. There is also a general distrust of the food industry and official regulators, following numerous scares from salmonella, through Escherichia coli, to bovine spongiform encephalopathy (BSE or mad cow disease). Opponents argue that, although consumers may be taking risks by eating genetically modified food, all the benefits go into the pockets of (often U.S.-owned) biotech companies. And there are genuine differences between farming practices in the United States and Europe, where many farms are still small and family-run and wildlife is dependent on particular farming techniques that critics fear will be changed by the new crops.
Yet the vehemence of the opposition to trials of genetically modified crops is surprising in view of Europe's willingness to embrace biotechnology for medical and other uses. There has, for example, been little ethical concern about the introduction of genetically engineered insulin for treating diabetes, or a genetically engineered version of the enzyme chymosin for cheesemaking. Ironically, because chymosin is traditionally extracted from calves' stomachs, the innovation has made cheese more acceptable for many vegetarians. And genetically modified food is already on sale: in 1996 Britain approved the sale of a tomato paste produced from plants modified to delay fruit-ripening, which was voluntarily labeled as genetically modified. The product sold well when it was introduced, says a spokesperson for one of the retailers selling it.
There are also clear signs that Europeans do see the benefits of genetic manipulation. In Switzerland, a national referendum in June on a proposal to severely restrict all transgenic research on animals and plants was defeated by a 2-to-1 margin (Science, 12 June, p. 1685). But it is not a blind acceptance. "In medical genetics, the public may have an eventual gain in terms of better diagnosis and treatment. By contrast, in agriculture the only clear beneficiaries of genetically modified crops are agrochemical companies, who get to retain their market share, while the public, and the environment, is left with the potential risks to their health," says biologist Tom Wakeford of the University of East London.
The trigger for the current wave of opposition was the unannounced arrival in Europe last year of products derived from genetically modified soybeans imported from the United States. Because there is no requirement to differentiate between modified and conventional beans in the United States, European consumers found that, unknowingly, they were eating foods that may have contained soybeans with genes for herbicide resistance. "I think that recent history with multinational companies bringing food products into Europe shows how important that early voluntary decision to label was," says geneticist Don Grierson, who led the work to develop the genetically modified tomato used in the tomato paste sold in Britain. "People were outraged because they wanted to be treated--rightly--as individuals with minds of their own," he says.
Although regulatory bodies have determined that the modified soybeans present no health hazards, tampering with the food chain without public consultation touches an extremely raw nerve--especially in Britain, which is still blighted by the legacy of BSE. "BSE was a watershed for the food industry in this country. For the first time people realized that merely attempting to ensure a culinary end product was safe to eat was not a good enough approach. We had to look at the entire process by which food is produced," says a spokesperson for Britain's Soil Association, which licenses organic growers.
There has also been a huge increase in demand across Europe for organically produced products. Already this year 140 British farmers have applied for accreditation as organic producers--445 are currently licensed--and the number of European organic producers has risen by 24% to 62,000 since 1996. Some countries, such as Sweden and Austria, are now almost 9% organic in terms of land area compared with about 2% 5 years ago.
More systematic samplings of public opinion have provided little comfort for the biotech industry. A "citizen's panel" project, organized by the University of East London earlier this year, provided an opportunity for 12 members of the public with no specialist knowledge of biotechnology to give their verdict on the technical issues following questions to a range of expert witnesses. The panel concluded that genetically modified foods provide no benefit to the consumer and that the risks they pose, both to long-term human health and to the environment, are unknown. However, they were not against laboratory research continuing into possible future benefits.
France also recently held a high-profile public "consensus conference" on genetically modified crops. A polling organization identified 14 lay people who had no prior scientific knowledge; they were then given intensive briefings and posed questions to experts. After that intense exposure to the issue, the panel called for the prohibition of antibiotic marker genes in transgenic crops, separation and labeling of transgenic and unmodified products, and a legal liability on any unforeseen consequences of introducing a transgenic product into food or the environment.
Environmental backlash
Public fears about safety are not the only problem agricultural biotech companies face in trying to market genetically modified products in Europe. Critics have also raised concerns about the possible environmental effects of introducing crops that European researchers are also beginning to find evidence of a potential environmental impact of genetically modified crops themselves and the need to monitor their effects carefully. Some groups have found evidence that genes from genetically modified crops can be transferred to native species via pollen. Other work by researchers at the Swiss Federal Research Station for Agroecology in Zurich has shown that lacewings, a natural predator of aphids, may be harmed by eating aphids on maize modified to express an insecticidal protein from Bacillus thuringiensis. Studies led by Nick Birch at the Scottish Crop Research Institute in Dundee have also found a similar effect with genetically modified potatoes containing a novel lectin, which reduces aphid attack without killing them. Ladybirds that feed on these aphids suffered significant loss of viability of their eggs compared to ladybirds feeding on control aphids. "There is a problem with monitoring programs. They have been a little bit forgotten," says Marcel Bruch, a biotechnology adviser to the Luxembourg government. But Swiss drug and agrochemicals giant Novartis says that extensive studies on its modified maize show that it is as safe as conventional maize in terms of its impact on beneficial insects and other wildlife.
Regulatory disharmony
Biotechnology companies hoping for relief on the regulatory front are facing disappointment there, too. The EU's attempts to ensure that uniform approval procedures for genetically modified crops are adopted across Europe seem to have stalled. In 1992, the European Commission, the EU's executive in Brussels, approved a directive spelling out licensing procedures for trials of genetically modified crops in the field and their commercial release. Each national government was required to incorporate it into its own law. According to the directive, if a crop is licensed for commercial growing following trials in one or more member states, then all member states must include the crop in their national lists of varieties approved for sale and cultivation.
That aim was soon put to the test. In 1995, the French government approved the commercial release in France of a genetically modified maize developed by Novartis. That approval was endorsed by the Commission in 1996 so that growers across all 15 member states could adopt the new crop. Austria and Luxembourg, however, refused to adopt it. Meanwhile, in France, after the Socialist Party wrested power
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Critics also contend that national licensing systems are open to abuse because safety data submitted to regulatory bodies comes from industry, and industry is also responsible for following up any permitted release. "They need to tear up [the directive] and start again," says biologist Mark Williamson of the University of York, who also presented evidence to Britain's House of Lords inquiry.
The European Commission is now consulting with interested parties on major amendments to the directive regulations. At the same time, the EU has also introduced plans to enforce the labeling of products containing genetically modified ingredients, starting later this year. But again, the plan has infuriated U.S. authorities. "The proposed [labeling] regulations have a questionable scientific basis and are ambiguous and impractical," says USDA's Galvin.
Biotech firms go public
Concern about public opinion has led the U.K. government to establish a new panel to develop public consultation on the future of the biosciences. Britain, which held the presidency of the EU for the first half of this year, championed the need to bolster biotechnology. The science minister, John Battle, told a special conference in Brussels in June that issues of public perception had to be addressed. "The debate about biotechnology is still to be won," he said. And Tom Wakeford, a member of the new consultation panel, says it will have to be careful to allow the public to distinguish between genetic engineering directed toward medical, as opposed to agricultural, applications. "There are fundamental differences in each case as to who are the risk takers and who are the beneficiaries," he says.
The biotechnology industry has also begun to take its case to the public. Monsanto has been running a newspaper advertising campaign in Britain and France, which now backs European calls for labeling of genetically modified products. In Britain, the BBSRC has launched a touring exhibit, In-gene-ious, to raise public awareness about biotechnology. Spokesperson Monica Winstanley says the stand has attracted a great deal of interest from farmers and the public wanting to know more about the technology. "We're trying to get to the bottom of what people are concerned about--concerns that are amenable to a realistic response." How the technology has been handled by the multinational companies is one perceived problem, she says. But some protesters have tried to block the message: At Britain's premier agricultural show last month pots of genetically modified wheat were attacked.
But in spite of current stiff resistance, even the European states that have taken the hardest line are keeping the door slightly ajar. "We don't, in principle, oppose the development of biotechnology," says Georg Rebernig, a member of the Austrian representation to the EU in Brussels. "Our concern is that there is greater transparency and harmonization on risk assessment," he says. "The biotechnology industry has huge potential, but it can't force products down people's throats. It's vital the industry does everything possible to regain the trust of the people."
Others also believe the industry can reverse its current fortunes in Europe. "Our view is that we need more time to do more research on the wider impacts of genetically modified crops. This first generation of crops can be seen as quick and dirty. We'd like to see more sophisticated gene modification of crops and their assessment to show that they don't damage the environment," says Johnson of English Nature. "We support the development of genetically modified crops that can bring environmental benefits."
